Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Zentalis Pharmaceuticals Inc (ZNTL)

99 + Investors. Track Smart Money conviction in ZNTL. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +16
Streak
1Q ▲
Buyers last Q
60%

Smart Money Signals — ZNTL

Based on 100 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added ZNTL than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 70% of 3.0Y peak

70% of all-time peak
100 funds currently hold this stock — 70% of the 3.0-year high of 143 funds (reached 2024 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📉

Outflows — 25% fewer funds vs a year ago

fund count last 6Q
33 fewer hedge funds hold ZNTL compared to a year ago (-25% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟢

More buyers than sellers — 60% buying

55 buying37 selling
Last quarter: 55 funds were net buyers (26 opened a brand new position + 29 added to an existing one). Only 37 were sellers (27 trimmed + 10 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+18 vs last Q)

new funds entering per quarter
Funds opening a new ZNTL position: 22 → 5 → 8 → 26. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

50% of holders stayed for 2+ years

■ 50% conviction (2yr+) ■ 30% medium ■ 20% new
50 out of 100 hedge funds have held ZNTL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +76% but shares only +12% — price-driven

Value
+75%
Shares
+11%
Last quarter: the total dollar value of institutional holdings rose +76%, but actual share count only changed +12%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📈

Growing discovery — still being found

18 → 22 → 5 → 8 → 26 new funds/Q
New funds entering each quarter: 22 → 5 → 8 → 26. A growing number of institutions are discovering ZNTL each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 56% veterans vs 26% newcomers

■ 56% veterans ■ 18% 1-2yr ■ 26% new
Entry-cohort mix of 104 holders: 58 (56%) are 2+ year veterans, 19 entered 1–2 years ago, and 27 (26%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 29% AUM from major funds

29% from top-100 AUM funds
26 of 100 holders rank in the top 100 by AUM, accounting for 29% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
2.0
out of 10
Low Exit Risk
Exit risk score 2.0/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ZNTL

In 2026 Q1, 55 hedge funds were net buyers of ZNTL (26 opened a new position, 29 added to an existing one), while 37 reduced or exited (27 trimmed, 10 sold completely) — a 60% buyer ratio, indicating clear institutional accumulation. 29% of total institutional value in ZNTL is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +16 funds (more new holders than closures). Total institutional holders: 100.

Hedge Fund Ownership: ZNTL

How many hedge funds hold ZNTL — quarterly history vs. share price
Quarterly hedge fund ownership of ZNTL vs. share price

Market Analysis: ZNTL

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ZNTL

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Zentalis Pharmaceuticals Inc (ZNTL) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ZNTL has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 80d ago
ZNTL
nan%
XLV
+2.1%

ZNTL outperformed XLV by nan% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 35d ago
ZNTL
nan%
XLV
+3.2%

Since the filing became public, ZNTL outperformed XLV by nan% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

10 top-rated funds 2 high-conviction
Consensus
4.5
/ 10
breadth
×
Elite
1.8
/ 10
conviction
Hedge Fund Positioning: ZNTL
99 + Investors

Track Smart Money conviction in ZNTL. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 99 84 17.86%
13F Shares 45M 41M 11.77%
Total Value $96M $55M 75.58%
New Positions 25 8 +17
Increased Positions 29 28 +1
Closed Positions 10 23 -13
Reduced Positions 27 29 -2
Total Calls 1 0 100%
Total Puts 2 0 100%
PUT/CALL Ratio 2.0 0.0 Bearish

Statistics: ZNTL

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

99 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ZNTL. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ZNTL holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Squadron Capital Management LLC 3.11% 3,631,000 $8.5M
2 Ishara Investments LP 2.72% 1,230,000 $2.9M
3 5AM Venture Management, LLC 2.56% 3,947,913 $9.2M
4 Pfizer Inc 0.84% 953,834 $2.0M
5 Peapod Lane Capital LLC 0.68% 366,868 $835K
6 Decheng Capital LLC 0.47% 1,323,327 $3.1M
7 Opaleye Management Inc. 0.44% 1,412,656 $3.3M
8 CDC Financial, Inc. 0.42% 283,762 $664K
9 Squadron Capital Management LLC 0.34% 400,000 $936K
10 Almitas Capital LLC 0.32% 610,073 $1.4M
11 Stonepine Capital Management, LLC 0.25% 269,100 $630K
12 Anfield Capital Management, LLC 0.18% 274,516 $642K
13 Seven Fleet Capital Management LP 0.08% 110,000 $257K
14 CTC Alternative Strategies, Ltd. 0.07% 12,500 $29K
15 Quarry LP 0.06% 150,000 $351K
16 Regency Capital Management Inc.\DE 0.03% 29,500 $69K
17 Carson Advisory Inc. 0.03% 23,270 $54K
18 Birchview Capital, LP 0.02% 17,503 $41K
19 ADAR1 Capital Management, LLC 0.02% 144,636 $338K
20 Barr E S & Co 0.01% 110,000 $257K
21 XTX Topco Ltd 0.01% 322,507 $755K
22 49 Wealth Management, LLC 0.01% 66,401 $155K
23 Sivia Capital Partners, LLC 0.01% 20,000 $47K
24 Headlands Technologies LLC 0.01% 29,899 $70K
25 State of Wyoming 0.01% 28,466 $67K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Zentalis Pharmaceuticals Inc (ZNTL)

What does the Smart Money Trend signal show for ZNTL?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added ZNTL than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ZNTL?

More buyers than sellers — 60% buying: Last quarter: 55 funds were net buyers (26 opened a brand new position + 29 added to an existing one). Only 37 were sellers (27 trimmed + 10 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ZNTL holders?

Strong quality — 29% AUM from major funds: 26 of 100 holders rank in the top 100 by AUM, accounting for 29% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ZNTL?

50% of holders stayed for 2+ years: 50 out of 100 hedge funds have held ZNTL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Zentalis Pharmaceuticals Inc (ZNTL) following the 2026 Q1 hedge fund 13F filings?

As of today, ZNTL has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), ZNTL has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →